Hanyang Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hanyang Sun has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ali Hassanpour
University of Leeds
1 shared publication - Alistair Bacchetti
School of Electronics and Electrical Engineering , University of Leeds, Woodhouse Lane, Leeds, LS6 9JT, Leeds, West Yorkshire, LS2 9JT, United Kingdom of Great Britain and Northern Ireland
1 shared publication - Andrew J. Britton
School of Chemical and Process Engineering, Faculty of Engineering and Physical Science, University of Leeds, Leeds LS2 9JT, UK
1 shared publication - Joshua Davy
STORM Lab School of Electronic and Electrical Engineering University of Leeds Leeds United Kingdom
1 shared publication - Jurgen E. Schneider
Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine University of Leeds Leeds UK
1 shared publication - Leah Khazin
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK
1 shared publication
Latest Publications
- Open Access
Theranostic Iron Oxide Nanoparticles for Controlled Oxaliplatin Release Under Simulated Circulation and Cytotoxicity Evaluation in Colorectal Cancer Cell Lines
Oxaliplatin (OXA) is a chemotherapeutic agent that suffers from poor pharmacokinetics and off-target toxicity. To enable controlled OXA release, we engineered a multi-functional iron oxide nanoparticle (IONPs) drug delivery system, based on pH-responsive mesoporous Fe3O4 (Fe3O4@MSN-NH2) nanoparticles (NPs), conjugated with folic acid (FA) for receptor-mediated targeting and guided by a magnetic robot platform (MRP) under simulated physiologically relevant dynamic circulation/flow system. For FA-conjugated NPs (Fe3O4@MSN-NH2/FA), ~29.73% OXA loading was achieved compared to ~10.3% in controls (Fe3O4@MSN-NH2/OXA), quantified by ICP-OES. Under dynamic circulation flow over 48 h, MRP enhanced pH-responsive OXA release (quantified by HPLC-UV), reaching ~92% and 88% (Fe3O4@MSN-NH2/OXA and Fe3O4@MSN-NH2/FA, respectively) at pH 5, versus 47% and 40% (Fe3O4@MSN-NH2/OXA and Fe3O4@MSN-NH2/FA, respectively) without MRP, demonstrating precise control in acidic tumor-mimicking conditions. MRI relaxometry exhibited strong T2-weighted contrast (T2 = 0.015 s at 50 μg/mL for Fe3O4@MSN-NH2/FA/OXA), confirming theranostic potential. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) studies revealed variable Folate receptor alpha (FOLR1) expression among colorectal cancer cell lines (Caco2, SW620, SW48, and T84), with Caco2 demonstrating high levels. MTT assays indicated selective targeting of FOLR1-positive cells by FA-functionalized NPs (Fe3O4@MSN-NH2/FA). This multi-functional drug delivery system integrates targeted delivery, MRP release, and real-time imaging, offering a promising technique for precision oncology.
Open AccessTheranostic Iron Oxide Nanoparticles for Controlled Oxaliplatin Release Under Simulated Circulation and Cytotoxicity Evaluation in Colorectal Cancer Cell Lines
Oxaliplatin (OXA) is a chemotherapeutic agent that suffers from poor pharmacokinetics and off-target toxicity. To enable controlled OXA release, we engineered a multi-functional iron oxide nanoparticle (IONPs) drug delivery system, based on pH-responsive mesoporous Fe3O4 (Fe3O4@MSN-NH2) nanoparticles (NPs), conjugated with folic acid (FA) for receptor-mediated targeting and guided by a magnetic robot platform (MRP) under simulated physiologically relevant dynamic circulation/flow system. For FA-conjugated NPs (Fe3O4@MSN-NH2/FA), ~29.73% OXA loading was achieved compared to ~10.3% in controls (Fe3O4@MSN-NH2/OXA), quantified by ICP-OES. Under dynamic circulation flow over 48 h, MRP enhanced pH-responsive OXA release (quantified by HPLC-UV), reaching ~92% and 88% (Fe3O4@MSN-NH2/OXA and Fe3O4@MSN-NH2/FA, respectively) at pH 5, versus 47% and 40% (Fe3O4@MSN-NH2/OXA and Fe3O4@MSN-NH2/FA, respectively) without MRP, demonstrating precise control in acidic tumor-mimicking conditions. MRI relaxometry exhibited strong T2-weighted contrast (T2 = 0.015 s at 50 μg/mL for Fe3O4@MSN-NH2/FA/OXA), confirming theranostic potential. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) studies revealed variable Folate receptor alpha (FOLR1) expression among colorectal cancer cell lines (Caco2, SW620, SW48, and T84), with Caco2 demonstrating high levels. MTT assays indicated selective targeting of FOLR1-positive cells by FA-functionalized NPs (Fe3O4@MSN-NH2/FA). This multi-functional drug delivery system integrates targeted delivery, MRP release, and real-time imaging, offering a promising technique for precision oncology.